Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
| Revenue (Most Recent Fiscal Year) | $2.67B |
| Net Income (Most Recent Fiscal Year) | $-637.32M |
| PE Ratio (Current Year Earnings Estimate) | 28.90 |
| PE Ratio (Trailing 12 Months) | 28.08 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.29 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.95 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 24.86 |
| Pre-Tax Margin (Trailing 12 Months) | -17.04% |
| Net Margin (Trailing 12 Months) | -12.37% |
| Return on Equity (Trailing 12 Months) | 3.59% |
| Return on Assets (Trailing 12 Months) | 2.55% |
| Current Ratio (Most Recent Fiscal Quarter) | 6.57 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.89 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.13 |
| Inventory Turnover (Trailing 12 Months) | 1.56 |
| Book Value per Share (Most Recent Fiscal Quarter) | $317.38 |
| Earnings per Share (Most Recent Fiscal Quarter) | $2.29 |
| Earnings per Share (Most Recent Fiscal Year) | $11.78 |
| Diluted Earnings per Share (Trailing 12 Months) | $-10.36 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 28.52M |
| Free Float | 23.65M |
| Market Capitalization | $8.58B |
| Average Volume (Last 20 Days) | 0.24M |
| Beta (Past 60 Months) | 0.94 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 17.06% |
| Percentage Held By Institutions (Latest 13F Reports) | 65.24% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |